Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.33NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.62NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.391NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.448NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Q.1 (Alpha)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.46 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.99 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.213NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.12NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.341NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.89NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.23NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.30NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.315NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.204NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.50NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.170NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.232NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.84NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.76NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.301NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.269NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.234NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Z.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
V.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.22NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.282NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.131NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.274NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.25NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.235NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.65NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.45NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.165NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258.12NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.525NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.480NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.214NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.304NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.214.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.577NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.2.5.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AZ.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.270NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.227NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
U.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.28NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used